Resveratrol and Exercise: Performance, Muscle Adaptation & the Antioxidant Paradox

Resveratrol does not have a simple “good for exercise” effect. Human training studies are unusually contradictory. In one randomized trial of older men, 250 mg/day of trans-resveratrol blunted several beneficial cardiovascular adaptations to exercise. In another study of older men and women, 500 mg/day alongside exercise enhanced several skeletal-muscle adaptations.

That conflict is not a reason to ignore the evidence. It is the main lesson: resveratrol may interact with exercise biology differently depending on tissue, population, training program, dose and endpoint.

Resveratrol and exercise at a glance

Question	Human evidence
Does it improve VO2max?	Not reliably. One older-men trial found resveratrol blunted the exercise-induced improvement.
Does it improve muscle strength?	One small older-adult trial reported greater strength/power-related adaptations with resveratrol plus training.
Does it improve mitochondrial adaptation?	Possible in skeletal muscle; results depend on study context.
Does it improve cardiovascular training response?	Potentially the opposite in some older men; the Copenhagen trial found blunting.
Does it increase SIRT1 with training?	Not consistently; one exercise trial found no SIRT1 protein increase.
Is it a proven sports-performance supplement?	No.

Why resveratrol seems like it should help exercise

The theoretical case is strong. Resveratrol influences pathways linked to mitochondrial biology, oxidative stress, AMPK, PGC-1α and sirtuin signaling. Exercise activates several overlapping pathways.

That creates an intuitive hypothesis: combine exercise with resveratrol and the adaptations should become larger.

But exercise physiology contains an important complication. Some of the oxidative and cellular stress generated by training is not merely damage—it is also a signal that helps trigger adaptation.

The antioxidant paradox

Exercise creates transient reactive oxygen species and other stress signals. The body responds by increasing endogenous antioxidant defenses, mitochondrial capacity, vascular adaptations and other protective systems.

If an antioxidant-like compound dampens those signals too aggressively, it could theoretically reduce the training stimulus.

This idea is sometimes called the antioxidant paradox: reducing oxidative stress is not automatically beneficial if the stress signal itself participates in adaptation.

Resveratrol is more complex than a simple antioxidant, but the concept helps explain why one exercise trial found blunted adaptation.

Gliemann 2013: resveratrol blunted cardiovascular benefits

A randomized double-blind placebo-controlled trial enrolled 27 healthy, physically inactive older men. Both groups completed high-intensity exercise training for eight weeks. One group also took 250 mg/day of trans-resveratrol.

Exercise alone produced expected cardiovascular improvements. But adding resveratrol blunted several of them, including:

• improvement in VO2max
• blood-pressure adaptation
• favorable changes in blood lipids

The study also did not find an increase in SIRT1 protein with resveratrol.

This trial is one of the most important counterexamples to the assumption that every longevity-pathway compound enhances exercise.

What the Copenhagen study does not prove

It does not prove that resveratrol universally harms exercise adaptation. The study was small, male-only and focused on older previously inactive men undergoing a specific training program.

Its relevance to young athletes, women, resistance-training specialists or people with chronic disease is uncertain.

But it is strong enough that a supplement page should not promise that resveratrol automatically “boosts your workout.”

Alway 2017: muscle adaptations looked better

A different randomized trial studied 30 adults aged 65–80 who completed aerobic and resistance training for 12 weeks. Participants received either placebo or 500 mg/day of resveratrol.

The resveratrol-plus-exercise group showed stronger changes in several muscle-related endpoints, including:

• mitochondrial density
• muscle fatigue resistance
• knee-extensor torque and power
• muscle-fiber and cellular-adaptation measures

However, resveratrol did not provide an additional reduction in cardiovascular risk measures.

How can one study show blunting and another show enhancement?

The studies differ in several important ways:

Factor	Gliemann 2013	Alway 2017
Participants	Older inactive men	Older men and women
Dose	250 mg/day	500 mg/day
Training	High-intensity exercise focus	Aerobic + resistance exercise
Primary emphasis	Cardiovascular adaptation	Skeletal-muscle cellular/function adaptation
Main signal	Blunted cardiovascular benefits	Enhanced selected muscle adaptations

The apparent contradiction may therefore reflect different tissues and outcomes rather than one study simply being “right” and the other “wrong.”

Does resveratrol improve VO2max?

There is no reliable evidence that resveratrol improves VO2max beyond training. In the important older-men trial, the opposite occurred: the resveratrol group showed less improvement in VO2max than the exercise-plus-placebo group.

That makes resveratrol a poor candidate for a generic “cardio performance” claim.

Does resveratrol improve strength?

The Alway trial reported improvements in selected strength and power measures when 500 mg/day was added to a combined training program in older adults.

This is promising for aging-muscle research, but the study was small and measured multiple endpoints. Independent replication is needed before treating resveratrol as an established strength supplement.

Does resveratrol build muscle?

No convincing evidence shows that resveratrol alone builds clinically meaningful muscle mass. The positive exercise study focused on training adaptations and cellular outcomes, not resveratrol replacing resistance exercise or adequate protein.

Any muscle benefit should be framed as a possible modifier of training response, not an anabolic effect comparable to resistance training.

Does resveratrol increase mitochondria?

Experimental research strongly connects resveratrol to mitochondrial pathways, and the Alway human trial reported greater mitochondrial-density-related adaptation.

However, mitochondrial signals are not always accompanied by better whole-body performance. Human training adaptation is multidimensional.

What about AMPK and PGC-1α?

AMPK and PGC-1α are central to exercise and mitochondrial biology. A 2025 randomized metabolic study in adults with obesity and insulin resistance reported increased skeletal-muscle AMPK/ACC phosphorylation and PGC-1α expression after resveratrol.

That supports genuine human pathway activity. It still does not establish that the same intervention improves athletic performance.

What about SIRT1?

SIRT1 is often used to justify combining resveratrol with exercise. But human SIRT1 evidence is inconsistent.

The Gliemann training study did not show higher SIRT1 protein with supplementation, and the 2025 meta-analysis of 11 randomized trials found no significant overall increase in SIRT1 gene expression, protein expression or circulating SIRT1.

See Resveratrol and SIRT1.

Should athletes take resveratrol?

The evidence is not strong enough to recommend resveratrol as a general sports-performance supplement. A competitive athlete should be especially cautious about assuming antioxidant-like signaling modulation is always beneficial around training.

For endurance adaptation, the blunting trial is a meaningful warning signal. For older adults focused on muscle function, the Alway trial is encouraging but preliminary.

Should you take resveratrol before or after exercise?

No human evidence establishes an optimal pre-workout or post-workout timing strategy for resveratrol.

The interaction with training appears to occur over repeated supplementation rather than simply the few hours around one workout. Timing claims should therefore not be invented from general antioxidant theory.

Does taking resveratrol with exercise help older adults?

Possibly for selected skeletal-muscle adaptations, but not universally. The two most relevant human training studies in older adults point in different directions depending on what was measured.

That makes the best answer outcome-specific:

• muscle function/cellular adaptation: promising signal
• cardiovascular adaptation: possible blunting in one important trial

Could dose explain the difference?

The positive muscle trial used 500 mg/day, while the cardiovascular-blunting trial used 250 mg/day. But we cannot infer that 500 mg is “better” because the participants, training and endpoints differed too much.

A true dose-response exercise trial would be needed.

What about resveratrol for recovery?

There is not enough clinical evidence to claim that resveratrol reliably reduces soreness, speeds recovery or prevents overtraining. Lowering inflammatory or oxidative markers is not automatically equivalent to better recovery, because some post-exercise signaling helps drive adaptation.

Bottom line

Resveratrol and exercise is not a synergy story; it is an interaction story.

In older humans, resveratrol has been reported to enhance selected skeletal-muscle adaptations in one trial and blunt cardiovascular training benefits in another. That makes generic claims such as “resveratrol boosts workouts” or “resveratrol improves recovery” scientifically weak.

For the mechanistic context, see Resveratrol and SIRT1. For dose and safety, see Resveratrol Dosage and Side Effects. The exercise studies are mapped in the Resveratrol Data Center.